We envision a world without a risk for renal toxicity for compounds entering clinical stages of drug development. Cell4Pharma aims to reduce the failure rate in late clinical stages due to renal tox below 3% market wide within the next 10 years. Without the use of animal experimentation. This ambition is supported by our human renal cell line ciPTEC validated during extensive collaborations with the pharmaceutical industry. More than 10 years of research lead to the development of robust cell-based assays focusing on the detection of highly specific biomarkers for renal toxicity.
| Website | https://www.cell4pharma.com/ |
| Revenue | $3 million |
| Employees | 6 (3 on RocketReach) |
| Phone | +31 6 22351074 |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Drug Development, Pharmaceutical Research, Toxicology, Drug Safety, Clinical Stage, Clinical Trials, Compound Development, Preclinical Studies, Drug Metabolism, Fda Approval, Biopharma, Pharmacokinetics, Pharmacodynamics, In Vivo Studies, In Vitro Studies |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, Sanofi, AstraZeneca, Bristol Myers Squibb, Gilead Sciences, Pfizer, Amgen +34 more (view full list) |
| SIC | SIC Code 737 Companies, SIC Code 80 Companies, SIC Code 73 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 51 Companies, NAICS Code 62151 Companies, NAICS Code 518 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 621 Companies |
Looking for a particular Cell4Pharma employee's phone or email?
Cell4Pharma Questions
The Cell4Pharma annual revenue was $3 million in 2026.
Ron Byron is the CEO and Co-founder of Cell4Pharma.
3 people are employed at Cell4Pharma.
The NAICS codes for Cell4Pharma are [51, 62151, 518, 6215, 62, 621].
The SIC codes for Cell4Pharma are [737, 80, 73, 283, 28].
Top Cell4Pharma Employees
-
Ron Byron
CEO and Co-founder at Cell4Pharma
Oss, NB, NL15 -
Peter Boogaard
Scientific Director at Cell4Pharma
Amsterdam, NH, NL1 -
Tom Weijers
Lab Manager at Cell4Pharma
Heumen, GE, NL1
Related Companies
